Active	Status	Sponsor type	Region	Phase	Filter
5 Active 2 Inactive 7 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Schadde, Erik
DRAGON, NCT04272931: 1- Training, Accreditation, Implementation and Safety Evaluation of Combined PVE/HVE	Active, not recruiting	N/A	111	Europe, Canada, US, RoW	Portal and Hepatic Vein Embolization, Liver venous deprivation (LVD), Double embolization	Maastricht University, Koningin Wilhelmina Fonds	Colorectal Cancer Liver Metastases	10/22	12/23
DRAGON 2, NCT05428735: The Trial	Recruiting	N/A	348	Europe, Canada, US, RoW	Embolization	Maastricht University	Colorectal Cancer Liver Metastases (CRLM), Small Future Liver Remnant (FLR)	06/26	06/29
Schaefer, Niklaus
iPREDICT, NCT05013099 / 2021-005610-33: Study of Zirconium Zr 89 Crefmirlimab Berdoxam PET/CT in Subjects With Advanced or Metastatic Malignancies	Active, not recruiting	2	70	Europe, US, RoW	zirconium Zr 89 crefmirlimab berdoxam, 89Zr-Df-crefmirlimab, 89Zr-Df-IAB22M2C	ImaginAb, Inc.	Melanoma, Merkel Cell Carcinoma, Unspecified, Renal Cell Carcinoma, Non Small Cell Lung Cancer	07/25	07/25
FAPIHN, NCT06794372: [68Ga]Ga-FAPI-46 in Staging of Head and Neck Carcinomas	Not yet recruiting	2	20	Europe	[68Ga]Ga-FAPI-46 PET/CT	John O. Prior	Head and Neck Squamous Cell Carcinoma HNSCC	10/26	12/26
Tilmanocept, NCT04663126: Feasibility of IV Tc-99m-tilmanocept for Imaging of M2-like TAMs in Metastatic Melanoma	Terminated	1	5	Europe	Tc-99m tilmanocept, Lymphoseek	John O. Prior	Melanoma	01/23	06/23